• Pcbp1, Mitochondrial Integrity, and B Cell Immunity

  2026-08-23

  The reference study identifies the RNA-binding protein Pcbp1 as a posttranscriptional regulator that sustains mitochondrial complex I function, protein translation, and antibody production in B cells. Its mechanistic link to Fdxr mRNA and mitochondrial iron–sulfur cluster biology provides a framework for studying how organelle integrity shapes germinal center responses and suggests complementary strategies for measuring nascent protein synthesis.

• Resazurin Sodium Salt in Translational Cell Models

  2026-08-22

  How Resazurin sodium salt can add a scalable metabolic viability layer to iPSC, disease-modeling, and drug-development workflows without replacing mechanism-specific functional assays.

• Licoricidin in HCC: PI3K/AKT, Growth, and Metastasis

  2026-08-21

  A 2026 study reports that licoricidin suppresses hepatocellular carcinoma growth and metastatic behavior through apoptosis, S-phase arrest, epithelial–mesenchymal transition changes, and inhibition of PI3K/AKT signaling. Its integrated cell-based and mouse-model design provides a useful framework for connecting phenotypic anticancer effects with pathway-level molecular evidence, while leaving important questions about direct target engagement and clinical translation unresolved.

• Berberrubine and NAFLD: Metabolism and Microbiota

  2026-08-21

  Yang et al. investigated whether berberrubine, a major berberine metabolite, directly contributes to protection against non-alcoholic fatty liver disease. Using high-fat diet-fed mice, oleic acid-treated HepG2 cells, metabolic protein analyses, and 16S rRNA sequencing, the study linked berberrubine with improved hepatic steatosis, insulin resistance, glucose and lipid regulation, and gut-microbiota remodeling.

• S1P/S1PR3 Signaling in Neuronal Apoptosis After ICH

  2026-08-20

  The reference study identifies an S1P–S1PR3 axis that links acute intracerebral hemorrhage to CCL2 and TNF-α expression, PI3K/AKT-associated signaling, and caspase-3 activation in neurons. Mouse and HT22-cell experiments suggest that pharmacological S1PR3 blockade reduces apoptosis and improves injury-associated outcomes, positioning S1PR3 as a mechanistic target for secondary brain injury research.

• RPS6 as a Translational Readout in PDAC

  2026-08-20

  The LRRC8A–Caveolin-1 axis links membrane homeostasis to KRAS/EGFR signaling, ribosome biogenesis, and pancreatic cancer growth. This thought-leadership guide explains how total RPS6 measurements can help translational researchers connect pathway perturbation with biosynthetic output using a rigorous, research-focused assay strategy.

• Degarelix Acetate: Evidence from the 2009 Review

  2026-08-19

  Laurence Klotz’s 2009 review examined Degarelix acetate as a third-generation GnRH receptor antagonist designed to suppress androgen production without the testosterone flare associated with GnRH agonists. Its clinical evidence emphasized rapid medical castration, early prostate-specific antigen responses, and a safety profile broadly comparable to agonist therapy, while also clarifying how endocrine endpoints should be interpreted in prostate cancer research.

• L-Alanyl-L-Glutamine: A Barrier-First Assay Guide

  2026-08-19

  L-Alanyl-L-glutamine is more than a glutamine-delivery format: it is a useful model compound for studying mucosal resilience, barrier function, and catabolic stress. This evidence-aware guide connects gastrointestinal assay design with orthogonal peptide research without overstating what the literature proves.

• CRTC–CREB Sensing of Proteotoxic Stress in Drosophila

  2026-08-18

  The reference study identifies the CRTC–CREB axis as a conserved transcriptional sensor that links proteasome inhibition to ROS/JNK signaling and stress-adaptive gene expression. Using Drosophila, cultured cells, transcriptomics, and a Huntington’s disease model, the authors show that enhancing CRTC/CREB activity can improve proteostasis and reduce protein aggregation, while also defining important limits for translating these findings beyond the fly system.

• Nanoparticle mRNA Delivery Reverses Trastuzumab Resistance

  2026-08-18

  The reference study developed a tumor-microenvironment pH-responsive nanoparticle system for systemic delivery of PTEN mRNA to trastuzumab-resistant HER2-positive breast cancer models. Its central finding is that restoring PTEN expression can inhibit persistently active PI3K/Akt signaling and improve trastuzumab response, illustrating how regulated mRNA delivery can address acquired therapeutic resistance.

• In Vitro Drug Response: Arrest Versus Cell Death

  2026-08-17

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing why growth inhibition and cell killing should not be treated as interchangeable endpoints. This framework helps researchers design more informative in vitro drug-response studies and interpret apparent efficacy with greater mechanistic precision.

• Mouse Tissue Lysis Kit (K1038) Workflow Guide

  2026-08-16

  The Mouse Tissue Lysis Kit (K1038) provides a rapid route from mouse tail, toe, or ear tissue to a lysate suitable for direct PCR-based genotyping, without a separate DNA extraction or purification step. It is intended for molecular biology research and DNA analysis, not for diagnostic, clinical, or medical use.

• Thiamet G: A Flux-Aware O-GlcNAc Strategy

  2026-08-15

  Thiamet G is a selective O-GlcNAcase inhibitor for testing how O-GlcNAc signaling links metabolism with cell fate. This article presents a flux-aware assay framework grounded in Wnt-driven osteogenesis, while clarifying implications for tauopathy and cancer models.

• Cy5-UTP RNA Labeling: Workflow and Troubleshooting

  2026-08-15

  Cy5-UTP enables direct fluorescent RNA probe synthesis for FISH, RNA–protein partitioning assays, and dual-color expression arrays. This practical guide connects labeling density, cleanup, imaging, and controls to the phase-separation biology of a plant virus movement protein.

• Thymosin-β4, Notch/NF-κB, and Limb Ischemia

  2026-08-14

  The reference study shows that thymosin-β4 enhances endothelial viability, migration, and tube formation in cellular and mouse models of critical limb ischemia, while increasing angiogenesis-associated markers. Its principal innovation is the use of pathway inhibition and rescue experiments to connect these effects with coordinated Notch and NF-κB signaling.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page